RBC Capital analyst Craig Wong-Pan upgraded ResMed (NYSE: RMD) from Sector Perform to Outperform with a price target of $262.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE